Cellid, Co., Ltd.

Cellid, Co., Ltd. - PE Ratioverified

299660.KQ

Price:

$1758

Market Cap:

$51.87B

Cellid, a South Korean firm established in 2006, specializes in creating immunotherapeutic vaccines designed to combat various cancers and infectious ailments. Their pipeline includes BVAC-C, which targets cervical, head and neck, anal, and genital cancers linked to the human papillomavirus (HPV) antigen. They are also advancing BVAC-B for gastric, ovarian, lung, and pancreatic cancers, focusing on the HER-2/neu antigen, and BVAC-P, intended for prostate, urinary tract, and brain cancers by leveraging PAP/PSMA antigens. Furthermore, Cellid is working on BVAC-M for melanoma and other cancers, utilizing GP100/MAGE-A3 antigens, alongside BVAC-Neo, a personalized immunotherapeutic vaccine soluti...[Read more]

Industry

Medical - Pharmaceuticals

IPO Date

2019-02-19

Stock Exchange

KOE

Ticker

299660.KQ

The PE Ratio as of August 2026 (TTM) for Cellid, Co., Ltd. (299660.KQ) is -0.99

According to Cellid, Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -0.99. This represents a change of -86.31% compared to the average of -7.23 of the last 4 quarters.

Cellid, Co., Ltd. (299660.KQ) Historical PE Ratio (quarterly & annually)

How has 299660.KQ PE Ratio performed in the past?

The mean historical PE Ratio of Cellid, Co., Ltd. over the last ten years is -40.34. The current -0.99 PE Ratio has changed 145.41% with respect to the historical average. Over the past ten years (40 quarters), 299660.KQ's PE Ratio was at its highest in in the June 2020 quarter at 1.43K. The PE Ratio was at its lowest in in the March 2019 quarter at -215.62.

Quarterly (TTM)
Annual

Average

-40.34

Median

-28.42

Minimum

-126.63

Maximum

-3.93

Cellid, Co., Ltd. (299660.KQ) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Cellid, Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 187.57%

Maximum Annual PE Ratio = -3.93

Minimum Annual Increase = -86.29%

Minimum Annual PE Ratio = -126.63

Quarterly (TTM)
Annual
YearPE RatioChange
2025-6.99-3.98%
2024-7.2883.56%
2023-3.970.99%
2022-3.93-86.29%
2021-28.66-61.64%
2020-74.70-7.85%
2019-81.07187.57%
2018-28.19-32.87%
2017-41.99-66.84%
2016-126.63-65.74%

Cellid, Co., Ltd. (299660.KQ) Average PE Ratio

How has 299660.KQ PE Ratio performed in the past?

The current PE Ratio of Cellid, Co., Ltd. (299660.KQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-6.08

5-year avg

-10.16

10-year avg

-40.34

Cellid, Co., Ltd. (299660.KQ) PE Ratio vs. Peers

How is 299660.KQ’s PE Ratio compared to its peers?

Cellid, Co., Ltd.’s PE Ratio is greater than Sugentech Inc. (-2.75), less than P&S Robotics Co., Ltd. (19.69), less than Ildong Holdings Co., Ltd. (2.35), greater than Oncocross Co., Ltd. (-4.32), less than Aprogen Biologics Inc. (-0.33), greater than iNtRON Biotechnology, Inc. (-8.36), less than Hyundai Pharmaceutical Co., Ltd. (35.92), less than CG Invites Co., Ltd. (181.00), less than DongKook Life Science (0), less than Shinhung Co., Ltd (23.80),

Build a custom stock screener for Cellid, Co., Ltd. (299660.KQ) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cellid, Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cellid, Co., Ltd. (299660.KQ) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cellid, Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Cellid, Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Cellid, Co., Ltd. (299660.KQ)?

What is the highest PE Ratio for Cellid, Co., Ltd. (299660.KQ)?

What is the 3-year average PE Ratio for Cellid, Co., Ltd. (299660.KQ)?

What is the 5-year average PE Ratio for Cellid, Co., Ltd. (299660.KQ)?

How does the current PE Ratio for Cellid, Co., Ltd. (299660.KQ) compare to its historical average?